Investigating the role of TAK1 in immune signaling and inflammation
TAK1 signaling pathways
This study is looking at how a specific signaling pathway in our immune system responds to infections and causes inflammation and cell death, with the goal of finding new ways to treat inflammatory diseases and cancers, especially in older adults.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | North Carolina State University Raleigh NIH-funded |
| Lab location | 1 site (Raleigh, United States) |
| Project ID | NIH-10992155 on NIH RePORTER |
What this research studies
This research focuses on understanding the TAK1 signaling pathways that are activated in response to infections and how they contribute to inflammation and cell death. By studying these pathways, the research aims to uncover the complex regulatory mechanisms of innate immunity, which could lead to new strategies for treating inflammatory diseases and cancers. The team utilizes various tissue-specific mouse models to explore how TAK1 influences both inflammatory responses and cell death processes. This work is crucial for developing better therapeutic approaches for age-related diseases and other inflammatory conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from age-related diseases, inflammatory disorders, or cancers.
Not a fit: Patients with non-inflammatory conditions or those not affected by age-related diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for inflammatory diseases and cancers, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in targeting similar immune signaling pathways, indicating potential for success in this area.
Where this research is happening
Raleigh, United States
- North Carolina State University Raleigh — Raleigh, United States (Active)
Researchers
- Principal investigator: Ninomiya-Tsuji, Jun — North Carolina State University Raleigh
- Study coordinator: Ninomiya-Tsuji, Jun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.